Public-Health Alert: Respiratory Infections Rising Across U.S. States — What the Latest Estimates Show and What You Need to Know
By [Robert ] — Health Desk
Date: (based on latest CDC estimates, mid-November 2025)
.jpg)
A broad uptick in respiratory infections is underway across the United States, federal health data show, prompting renewed public-health attention as the nation moves into the winter respiratory season. The Centers for Disease Control and Prevention’s (CDC) time-varying reproductive-number estimates — which use near-real-time emergency-department and other surveillance data to classify whether infections are growing, declining, or stable — indicate that influenza and other seasonal respiratory viruses are increasing in the majority of states, while COVID-19 activity is climbing in multiple regions as well. Public-health officials and hospitals are monitoring the trend closely because even moderate increases in transmission can translate into higher hospital use and strain on health systems during winter months. (CDC)
The data: what the CDC’s Rt estimates are telling us
The CDC’s epidemic-trend tool — which reports a time-varying reproduction number (Rₜ) and classifies epidemic trends by state — is signaling substantial growth for seasonal influenza: the agency’s public page reported that influenza infections were “growing or likely growing” in dozens of states in mid-November 2025. At the last public update, influenza was estimated to be growing or likely growing in roughly 42 states, with very few states showing declines. (CDC)
COVID-19 signals are more mixed but nonetheless notable. Multiple public reports and CDC-based summaries published in mid- to late-November indicate that COVID-19 infections were growing or likely growing in roughly 19–20 states, measured primarily by emergency-department visit data and other near-real-time indicators. Importantly, many health analysts stress that while the number of states with growth is significant, the absolute intensity of emergency-department activity for COVID in many places remains at “very low” to “low” levels compared with earlier pandemic peaks. Still, even low-level growth can accelerate rapidly under certain conditions (colder weather, increased indoor gatherings, waning immunity). (Newsweek)
Beyond those headline counts, the CDC’s respiratory-virus dashboards and state dashboards show rising activity for RSV in several regions and localized increases in other pathogens, including seasonal influenza A and B subtypes. The agency’s “respiratory virus activity levels” monitoring also notes increasing acute respiratory-illness visits in emergency departments in a number of states. These layered signals — Rₜ estimates, ED visit levels, wastewater detection and laboratory positivity — together paint a picture of multi-pathogen respiratory spread beginning to build across the country. (CDC)
Why the Rt measure matters (and its limits)
Rₜ — the effective reproduction number — estimates how many secondary infections one infected person causes on average at a given time. When Rₜ is above 1, infections are expected to grow; below 1, they should decline. The CDC’s Rₜ estimates combine nowcasted emergency-department visit data with modeling to provide timely snapshots of trend direction, which are particularly useful for identifying early increases before hospitalization data fully register.
However, Rₜ estimates are not a measure of disease severity or hospital burden by themselves. They reflect transmission dynamics. Because Rₜ is sensitive to recent changes in behavior (travel, gatherings), environmental conditions (indoor time, humidity), and immunity levels, it can fluctuate week to week. Additionally, reported Rₜ can be affected by changes in testing, health-seeking behavior, and the data sources used (for example, ED visits vs. laboratory reports vs. wastewater). Public-health experts therefore interpret Rₜ alongside hospitalizations, ICU use, and mortality to assess the practical impact on health systems. (ScienceDirect)
What the rising signals mean for hospitals and vulnerable populations
Even if many states report only modest or low absolute levels of ED visits related to respiratory viruses, the seasonal convergence of influenza, RSV and COVID-19 can increase hospital admissions — especially among older adults, very young children, and people with chronic conditions. Recent analyses of the 2024–2025 influenza season documented that older adults drove disproportionate hospitalizations and costs, signaling persistent vulnerability among the elderly even when overall community spread is moderate. Health systems and long-term-care facilities typically prepare for such seasonal surges by securing staffing, ensuring adequate oxygen and antiviral supplies, and reviewing surge protocols. (AJMC)
Hospitals in metropolitan areas and regions reporting concurrent growth across multiple viruses could see compounded impacts: longer inpatient stays for severe influenza or RSV, disrupted elective schedules, and greater demands on emergency departments. At the same time, health officials emphasize that vaccination, early antiviral treatment for influenza and COVID for eligible patients, and routine infection-control measures can blunt the worst system impacts. (AJMC)
Regional patterns — which states are showing growth?
State-level Rₜ summaries released by the CDC and media summaries in recent days show that growth patterns are geographically variable. Some Midwest and central states have shown rising COVID-19 signals; parts of the South and Southeast are seeing increases in RSV activity; and many states across the Northeast and Midwest are registering influenza growth. News outlets referencing CDC outputs in mid-November listed roughly 19 states with COVID growth signals and a larger number with influenza upticks — this patchwork pattern is typical at the start of seasonal waves. Because the CDC updates these indicators frequently, the list of specific states can shift week to week and should be checked on the CDC site for the most current state-level classification. (Newsweek)
Why respiratory viruses are resurfacing now
Epidemiologists point to several overlapping factors that help explain the seasonal rebound:
-
Seasonality and behavior: Colder weather pushes people indoors, where respiratory viruses transmit more readily. Holiday travel and gatherings increase close contacts and opportunities for spread.
-
Waning immunity: Immunity from prior infection or vaccination diminishes over time, leaving some people susceptible to reinfection. Booster uptake for COVID-19 and annual influenza vaccination varies widely by age and risk group.
-
Viral evolution: SARS-CoV-2 continues to change; new variants can alter transmissibility or immune escape. Influenza virus subtypes vary year to year, affecting how well prior immunity protects communities. Surveillance signals in wastewater and sequencing programmes occasionally indicate the rise of new lineages that merit attention. (The Guardian)
Experts stress that these are normal drivers of seasonal respiratory epidemics, but they become more consequential when several viruses rise at once or when immunity in at-risk groups is low.
What public-health authorities are recommending now
Federal and state public-health agencies have a consistent set of practical recommendations to reduce transmission and protect vulnerable people:
-
Vaccination: Get an updated COVID-19 booster if you are in an eligibility group and haven’t received the current season’s shot; get an annual influenza vaccine — both reduce risk of serious illness. Health agencies emphasize older adults, pregnant people, and those with chronic illnesses should be prioritized for vaccination. (CDC)
-
Testing and early treatment: People with symptoms should test for COVID-19 and influenza where possible and seek medical advice. Antiviral treatment for influenza (e.g., oseltamivir) and authorized COVID antiviral therapies are most effective when started early. Clinicians use current guidance to decide testing and treatment pathways. (CDC)
-
Infection-control practices: Improve ventilation, use masks in crowded or high-risk settings (especially around vulnerable individuals), stay home when sick, and practice hand hygiene. These measures reduce transmission across multiple respiratory pathogens.
-
Protect institutions: Long-term-care facilities, hospitals, and schools should review infection-control and surge plans, promote vaccination among staff, and ensure rapid testing availability.
-
Stay informed: Consult local health department dashboards and the CDC’s surveillance updates for the latest local activity and guidance. (CDC)
The role of wastewater and syndromic surveillance
Traditional lab testing and hospitalization data are informative but often lag behind community transmission. To catch early signals, public-health agencies use wastewater surveillance, syndromic surveillance (ED visit patterns) and time-varying Rₜ models. Wastewater monitoring can detect viral genetic material days to weeks before increases appear in clinical testing and has been used effectively to track COVID-19 and, more recently, other viruses like measles in pilot projects. Syndromic indicators — such as emergency-department acute-respiratory-illness visit levels — feed into the CDC’s near-real-time trend models that inform the Rₜ classifications being reported now. Combined, these tools help authorities act earlier in the cycle. (TIME)
What this means for schools, workplaces and travel
As respiratory activity picks up:
-
Schools should reinforce policies for symptomatic students and staff to stay home, encourage vaccination clinics, and keep sick-child protocols clear. Outbreaks in congregate settings (classrooms, daycare) can disrupt learning and childcare, so early testing and isolation remain key.
-
Workplaces should consider flexible sick-leave policies to discourage presenteeism (going to work while ill), enhance indoor air quality where feasible, and promote vaccination among employees. Remote work options can be an effective mitigation strategy when community spread rises.
-
Travelers should be aware that holiday travel increases exposure risk. Testing before visiting high-risk individuals (older adults, immunocompromised) and staying current on vaccines are strongly recommended. Masking during long transit periods (airports, flights) reduces exposure risks on crowded conveyances.
Balancing vigilance with perspective
Public-health leaders caution against panic. Multiple data streams indicate many states remain at low absolute levels of medical visits for respiratory viruses, and vaccines and treatments reduce severe outcomes for most people. But public-health strategy emphasizes prevention and early protection — not just reaction — because taking steps now can substantially reduce severe illness and system stress later in the winter.
Health authorities also underscore equity: communities with low vaccination uptake, limited healthcare access, or higher prevalence of chronic disease are more likely to experience worse outcomes. Targeted outreach, mobile vaccination clinics, and partnerships with community organizations are vital components of the response for protecting these groups. (AJMC)
How clinicians and hospitals are preparing
Hospitals typically prepare for winter respiratory seasons by:
-
Reviewing surge staffing plans and cross-training personnel.
-
Stockpiling key therapeutics and supplies (antivirals, oxygen delivery equipment, PPE).
-
Coordinating with regional public-health partners on bed capacity and transfers.
-
Accelerating vaccination campaigns for staff and patients, especially in long-term-care and transplant programs.
Health systems that faced high volumes in prior seasons are quick to mobilize surge playbooks; many smaller hospitals in rural regions remain vulnerable if local cases spike suddenly. The CDC’s early indicators allow some planning lead time, but nimble operational response is essential when multiple viral waves overlap. (AJMC)
A closer look at vulnerable groups
Certain populations carry outsized risk for severe outcomes:
-
Older adults (65+): Higher risk of hospitalization and death from influenza and COVID-19; driving much of the seasonal hospitalization burden.
-
Very young children: RSV in particular causes significant pediatric hospitalizations each season.
-
People with chronic cardiopulmonary disease, diabetes, immunosuppression: Higher risk of severe disease and complications.
-
Pregnant people: At increased risk for severe influenza and sometimes COVID-19 complications; vaccination is recommended.
Focused vaccination outreach, early treatment access and protective measures in congregate settings reduce risk among these groups. (AJMC)
What individuals can do (practical checklist)
-
Get your seasonal vaccines (influenza; COVID-19 booster if eligible).
-
If symptomatic, test for COVID-19 and influenza where tests are available; seek medical advice early if you are at risk.
-
Consider wearing a high-quality mask in crowded indoor settings, particularly if you or someone you live with is vulnerable.
-
Improve ventilation indoors (open windows, use HEPA purifiers) when possible.
-
Stay home when sick, and keep children home from school if symptomatic until testing or recovery guidance is followed.
-
Know where local vaccination clinics and testing centers are — your state or county health department website and the CDC locator pages are good starting points. (CDC)
Looking ahead: forecasts and uncertainties for the 2025–2026 season
Forecasting the peak and intensity of a seasonal respiratory wave is inherently uncertain. Key determinants include viral evolution (which may change transmissibility or immune escape), vaccine match and uptake, behavioral patterns around holiday gatherings, and the interaction of multiple viruses circulating at once.
Public-health models suggest that with current immunity levels and vaccine availability, widespread catastrophic surges remain unlikely if vaccination rates hold and early mitigation measures are applied. However, localized surges in hospitals — particularly in areas with lower vaccine coverage or with high concentrations of vulnerable adults — remain a realistic possibility. The coming weeks will be critical for monitoring whether current growth trends broaden nationally and whether hospitalizations rise in parallel. (CDC)
How reporters and the public can follow developments
-
CDC Rₜ and respiratory activity dashboards — the primary federal near-real-time trackers for epidemic trend categories and ED-based signals. (CDC)
-
State health department dashboards — for local hospitalization and testing metrics.
-
Wastewater surveillance portals — for early signals of viral concentration changes in communities.
-
Local hospital press offices — for updates on capacity, elective-procedure policies and surge plans.
Final word
The recent CDC trend estimates provide an early warning: multiple respiratory viruses — especially influenza and, in many states, COVID-19 — show rising transmission in mid-November 2025. For the average person, the immediate steps are practical and familiar: get vaccinated, stay home when sick, test early, and protect those at greater risk. For health systems, the message is preparedness: use the lead time these surveillance tools provide to shore up staffing, supplies and treatment access so that winter respiratory waves are managed with as little disruption as possible.
For ongoing, state-level updates and the latest guidance on vaccination and antivirals, consult the CDC’s surveillance pages and your local public-health department. (CDC)
Sources & further reading
-
CDC — Current Epidemic Trends (based on Rₜ) for States. (CDC)
-
American Hospital Association — “CDC data shows rise in flu, COVID-19 cases across states.” (American Hospital Association)
-
CDC — Respiratory Virus Activity Levels (syndromic surveillance). (CDC)
-
Newsweek / national media summaries — maps and state lists of COVID-19 growth. (Newsweek)
-
The American Journal of Managed Care — analysis of 2024–2025 influenza season impacts on older adults. (AJMC)
